Low-Severity Prescription Medication Histories: Good for Risks?
Individuals who have only low-severity medications in their prescription histories may not necessarily be those with the least mortality risk.
underwriting rx
New Medication for Alzheimer's Disease: What you need to know about Aducanumab
Aducanumab (Aduhelm), a new drug designed to treat Alzheimer's disease was approved by the FDA on June 7, 2021. RGA's Dr. Dave Rengachary discusses what this means for insurance, as well as the controversies around it.
Milliman Risk Score 2.0 – Stratifying Mortality Risk Using Prescription Drug Information
Munich Re assessed the Milliman Rx Risk Score, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Insurers considering prescription- drug-based scores should begin with a retrospective validation study on their own experience data.
Milliman IntelliScript Underwriting with Rx Based Models (Slides)
Slides from this presentation, given at the 2018 ACSW Spring Meeting, have been posted at the Actuaries’ Club of the Southwest website.
Presentations from the 2018 WAHLU Spring Seminar
Slides from the 2018 Wisconsin Association of Health and Life Underwriters have been posted at the WAHLU website.
Presentations include:
- Drugs: Startling trends, testing & tales
- Underwriting Asthma & COPD Using Rx
- Underwriting Alcohol-Related Risk
For New Antipsychotic Users, Dose, Duration Impact Mortality
Dose and duration of therapy are associated with mortality for new antipsychotic users, according to a study published online May 10 in the Journal of the American Geriatrics Society.
sponsored by:
